Related Experiment Video
Updated: Jun 18, 2026
09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
[Granulocytic sarcoma, a diagnostic challenge: 3 pediatric cases].
C Rénard1, S Girard, J P Pracros
1Institut d'hématologie et d'oncologie pédiatrique, 1, place Joseph-Renaut, 69008 Lyon, France. cecilerenard@wanadoo.fr
Summary
Granulocytic sarcoma (GS), a rare tumor often linked to acute myeloblastic leukemia (AML), can present in various pediatric locations. Early diagnosis is crucial, as pathology confirms GS, which is treated with chemotherapy, showing a potentially better prognosis than isolated AML.
Area of Science:
- Oncology
- Hematology
- Pediatric Pathology
Background:
- Granulocytic sarcoma (GS), also known as myeloid sarcoma, is an extramedullary tumor composed of immature granulocytes.
- It is frequently associated with acute myeloblastic leukemia (AML), but can also occur in isolation.
Observation:
- This report details three pediatric cases of granulocytic sarcoma with diverse anatomical sites: skin, orbit, and bowel.
- Two cases were concurrent with acute myeloblastic leukemia (AML), while one case presented as an isolated tumor.
- Diagnostic delays were noted in all three cases, highlighting the challenge in recognizing this rare entity.
Findings:
- Histopathology and immunohistochemistry were essential for accurate diagnosis of granulocytic sarcoma.
- Treatment for GS mirrors that of AML, typically involving chemotherapy.
- The prognosis for patients with granulocytic sarcoma, particularly when isolated, may be more favorable compared to isolated AML.
Implications:
- Increased awareness and prompt diagnostic evaluation are necessary for pediatric granulocytic sarcoma.
- Further research into the distinct biological behavior and treatment strategies for isolated GS is warranted.
- Understanding the varied presentations of GS can improve patient outcomes in pediatric oncology.